-
Cy3-UTP for Mapping RNA Architecture
2026-09-24
Cy3-UTP can make in vitro-transcribed RNA visible, but fluorescent signal is only useful when labeling is designed around the biology being measured. This article connects Cy3-modified uridine triphosphate to recent findings on 28S rRNA expansion segments, highlighting controls that help distinguish RNA localization from RNA-driven architecture.
-
Resazurin Sodium Salt for Metabolic Assay Design
2026-09-24
Resazurin sodium salt converts cellular reducing activity into a fluorescent signal, but that signal can shift when metabolism changes independently of cell number. This article connects assay interpretation to research on glutamine metabolism in hepatic stellate cells and offers practical guidance for using the readout responsibly.
-
BCA Protein Quantification Kit: K4102 Workflow
2026-09-23
The K4102 Bicinchoninic Acid Assay (BCA) Protein Quantification Kit measures total protein in dilute samples, including many preparations containing ionic or non-ionic detergents. Use it for research workflows such as cell-lysate normalization, not for diagnostic, clinical, or medical testing.
-
BCA Protein Quantification Kit K4102 Guide
2026-09-23
The BCA Protein Quantification Kit (SKU K4102) provides a practical method for measuring low-concentration total protein in biochemical samples, including many detergent-containing preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not for diagnostic, clinical, or medical use.
-
SIRT1, Resveratrol, and Mitochondrial Biogenesis
2026-09-22
The 2024 reference study identifies a SIRT1–PGC-1α–TFAM pathway that links prion peptide stress to impaired mitochondrial biogenesis, mitochondrial dysfunction, and apoptosis in N2a cells. Its use of resveratrol as a pharmacological SIRT1 activator supports a pathway-resolved neuroprotection workflow, while remaining limited to an in vitro prion-peptide model.
-
ICG001: Wnt/β-catenin Pathway Inhibitor Guide
2026-09-22
ICG001 provides selective control of CBP-dependent Wnt transcription, making it useful for cancer, fibrosis, and stem-cell mechanism studies rather than nonspecific pathway suppression. This guide translates that selectivity into practical cell, exosome, and disease-model workflows, with the lithium–osteogenesis study serving as a framework for designing pathway-rescue experiments.
-
Resiquimod (R-848) Assay Workflows
2026-09-21
Resiquimod (R-848) enables controlled TLR7/8 stimulation for innate immune response modulation, macrophage polarization, dendritic-cell activation, and cancer immunotherapy research. This guide translates a thermal-protective hydrogel study into practical assay designs, formulation controls, and troubleshooting decisions.
-
D-Luciferin Sodium Salt in CAR-M Assays
2026-09-21
D-Luciferin sodium salt is a firefly luciferase substrate that can add a quantitative metabolic layer to CAR-macrophage studies. This article explains how to use ATP-dependent bioluminescence without confusing reporter signal with immune function, using recent mRNA-LNP CAR-M research as the biological context.
-
Digoxin: A Context-First Research Strategy
2026-09-20
Digoxin is a Na+/K+ ATPase pump inhibitor whose effects depend strongly on cell type, exposure, and assay context. This guide connects cardiac contractility modulation with chikungunya research while translating pharmacology lessons from a landmark anticoagulant review into more rigorous experimental design.
-
Sulfo-Cy3 azide for Claustrum Birth-Dating Assays
2026-09-19
Sulfo-Cy3 azide adapts aqueous Click Chemistry fluorescent labeling to EdU-based developmental neuroanatomy, enabling bright spatial readouts alongside Nurr1 detection. Its water solubility and reduced dye–dye interactions are especially useful for tissue sections, intact samples, and quantitative fluorescent microscopy staining.
-
AM 281 for CB1 Signaling in TBI Research
2026-09-18
AM 281 enables selective interrogation of CB1 activity across receptor-binding, astrocyte, tissue, and behavioral assays. Its strongest differentiation is the ability to connect CB1-CREB signaling with GLT-1 regulation, glutamate excitotoxicity, and cognitive outcomes in traumatic brain injury models.
-
Isoprinosine Workflows for HSV-1 Research
2026-09-18
Isoprinosine enables a practical bridge between antiviral phenotyping and immune-response studies, with workflows that separate viral replication from nuclear egress. This guide combines product handling, CLCC1-informed assay design, quantitative endpoints, and troubleshooting for herpesvirus and respiratory-virus research.
-
BCA Protein Quantification Kit K4102
2026-09-17
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides sensitive total-protein measurement for dilute biochemical samples, including many detergent-containing preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not validated for diagnostic, clinical, or medical use.
-
Targeted NAC Nanoparticles Protect Cartilage in OA
2026-09-17
The reference study develops chondroitin sulfate-modified PLGA nanoparticles that deliver N-acetylcysteine to chondrocytes, maintain glutathione, and suppress ferroptosis in osteoarthritis models. Its use of GPX4-deficient mice strengthens the causal link between redox preservation and cartilage protection, while also highlighting the importance of localized, sustained intra-articular delivery.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-09-16
AZD8055 is a selective ATP-competitive mTOR inhibitor for investigating mTORC1 and mTORC2 signaling in biochemical, cellular, and selected preclinical models. It is useful for mechanistic pathway studies, but its poor water solubility, limited clinical benefit, and absence of directly matched paper evidence make it unsuitable for clinical efficacy conclusions.